English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51918503    Online Users :  1217
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lu ys"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 11-35 of 44  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2014-10 The association between medical history and breast cancer risk: A nationwide population-based case-control study using claim data Chuang, SC;Wu, GJ;Lu, YS;Lin, CH;Hsiung, CA
臺北醫學大學 2014 Distinct Clinicopat?hological Features and Prognosis of Emerging Young Female Breast Cancer in an East Asian Country: A Nationwide Cancer Registry-b?ased Study Lin, CH;Chuang, PY;Chiang, CJ;Lu, YS;Cheng, AL;Huang, CS;Lai, MS;You, SL;Tang, CH
國家衛生研究院 2011-05 Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 Kuo, SH;Hsu, CH;Chen, LT;Lu, YS;Lin, CH;Yeh, PY;Jeng, HJ;Gao, M;Yeh, KH;Cheng, AL
中國醫藥大學 2011-05 Cisplatin as an active treatment in zoledronate-refractory hypercalcemia 林柏翰(Po-Han Lin); 邱昌芳(Chang-Fang Chiu); (Lu, YS)*
中國醫藥大學 2010-07 Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation. 林柏翰(Po-Han Lin); (Lu YS); (Lin CH); (Chang DY); (Huang CS); (Cheng AL); (Yeh KH)*
國家衛生研究院 2009-09-15 Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL
國家衛生研究院 2009-06 Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin, CH;Liau, JY;Lu, YS;Huang, CS;Lee, WC;Kuo, KT;Shen, YC;Kuo, SH;Lan, C;Liu, JM;Kuo, WH;Chang, KJ;Cheng, AL
國家衛生研究院 2009-04-24 Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL
國立臺灣大學 2008-11 OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Gao, M; Yeh, PY; Lu, YS; Hsu, CH; Chen, KF; Lee, WC; Feng, WC; Chen, CS; Kuo, ML; Cheng, AL
國立臺灣大學 2008-11 NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. Gao, M; Yeh, PY; Lu, YS; Chang, WC; Kuo, ML; Cheng, AL
國家衛生研究院 2008-08 Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells Chen, KF;Yeh, PY;Yeh, KH;Lu, YS;Huang, SY;Cheng, AL
國立臺灣大學 2008-06 Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients. Kuo, SH; Lien, HC; You, SL; Lu, YS; Lin, CH; Chen, TZ; Huang, CS.
國立臺灣大學 2008-06 The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. Huang, CS; Kuo, SH; Lien, HC; Yang, SY; You, SL; Shen, CY; Lin, CH; Lu, YS; Chang, KJ.
國立臺灣大學 2008-02 Differential expression of glucocorticoid receptor in carcinomas of the human digestive system Lien, HC; Lu, YS; Shun, CT; Yao, YT; Chang, WC; Cheng, AL
國家衛生研究院 2007-06-01 Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS
國立臺灣大學 2007-03 Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國立臺灣大學 2006-12 Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. Lu, YS; Lien, HC; Yeh, PY; Yeh, KH; Kuo, ML; Kuo, SH; Cheng, AL.
國家衛生研究院 2006-05 Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT
國家衛生研究院 2006-02 Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappa B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa Lu, YS; Yeh, PY; Chuang, SE; Gao, M; Kuo, ML; Cheng, AL
國立臺灣大學 2005-10 Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. Lu, YS; Lien, HC; Yeh, PY; Kun-Huei, Yeh; Kuo, ML; Kuo, SH; Cheng, AL
國家衛生研究院 2005-09-14 Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ
國立臺灣大學 2005-08 Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL.
國立臺灣大學 2005-08 Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL.

Showing items 11-35 of 44  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page